chlorpromazine has been researched along with ponatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagola, K; Bettels, R; Booth, C; Chapel, H; Düker, G; Elkadri, A; Gyrd-Hansen, M; Jameson, E; Jung, J; Keshav, S; Koletzko, S; Kugathasan, S; Lachmann, RH; Marquardt, T; Muise, AM; Pandey, S; Patel, SY; Platt, FM; Platt, N; Powrie, F; Rohrbach, M; Runz, H; Schwerd, T; Shah, N; Uhlig, HH; Wraith, JE; Xavier, RJ; Yang, HT | 1 |
1 other study(ies) available for chlorpromazine and ponatinib
| Article | Year |
|---|---|
Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Anti-Bacterial Agents; Autophagy; Bacteria; Cells, Cultured; Child; Child, Preschool; Chlorpromazine; Crohn Disease; Dopamine Antagonists; Female; Genetic Diseases, X-Linked; Gentamicins; Granuloma; Humans; Imidazoles; Leukocytes, Mononuclear; Lysosomes; Macrophages; Male; Mutation; Niemann-Pick Disease, Type C; Nod2 Signaling Adaptor Protein; Protein Kinase Inhibitors; Pyridazines; Receptor-Interacting Protein Serine-Threonine Kinase 2; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein; Young Adult | 2017 |